Elderly: Clinical Trials

7 trials for Elderly, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 7
Phase 13Unknown 3
Phase 31Unknown 1

Follow Elderly: new trials by email Literature Review of Elderly trials Research Report on Elderly

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NK Cell Therapy Recurrent/Refractory Elderly AML
Allogeneic NK cell regimen group - AML, Recurrent
Phase 1 / Phase 2UnknownThe Second Hospital of Shandong University102020-12-012020-10-22
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
Decitabine, Busulfan (BU), Fludarabine(Flu) - Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University602018-06-152020-12-22
TNS for Treating Major Depressive Disorder in the Elderly
Transcutaneous Trigeminal Nerve Stimulation - Major Depressive Disorder, Elderly
Phase 1 / Phase 2UnknownSanta Casa Medical School102015-10-012015-09-29
The Role of Mind Body Therapy in Geriatric Rehabilitation
mind-body intervention - Elderly, Treatment
Phase 1 / Phase 2UnknownTel-Aviv Sourasky Medical Center2010-01-012010-02-05
Utilizing Tailored Step-Count Feedback to Enhance Physical Activity in the Elderly
Web Mediated Step Intervention - Physical Activity, Elderly
Phase 2UnknownUniversity of Wisconsin, Milwaukee1602009-08-012015-05-28
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
S-1 (TS-1) and Oxaliplatin (Oxalitin) - Elderly, S-1
Phase 2UnknownSoonchunhyang University Hospital362009-08-012009-08-18
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Azacitidine - Acute Myeloid Leukemia, Elderly
Phase 2UnknownKansas City Veteran Affairs Medical Center402008-07-012008-08-06

Narrower conditions

Leukemia, Myeloid, Acute (2)  ·  Recurrence (2)  ·  Depressive Disorder, Major (1)  ·  Leukemia (1)  ·  Motor Activity (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Depressive Disorder (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Leukemia (1)

Interventions

Azacitidine (1)  ·  Busulfan (1)  ·  Decitabine (1)  ·  Oxaliplatin (1)  ·  S 1 (combination) (1)  ·  titanium silicide (1)

Sponsors

Kansas City Veteran Affairs Medical Center (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Santa Casa Medical School (1)  ·  Soonchunhyang University Hospital (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  The Second Hospital of Shandong University (1)  ·  University of Wisconsin, Milwaukee (1)

Countries

China (2)  ·  United States (2)

Top investigators

Amit Verma, MD (1)  ·  Chengyun Zheng, Ph.D. (1)  ·  Qifa Liu (1)  ·  Sang-Cheol Lee, M.D. (1)  ·  Scott J Strath, PhD (1)

Results publications

PMID 25054988, PMID 25150403, PMID 40831735

NIH funding

K01AG025962 (1)